EE233 Cost-Effectiveness of Adjuvant Alectinib vs. Platinum-Based Chemotherapy in Resected Stage IB-IIIA ALK-Positive NSCLC: A French Health Economic Evaluation
Abstract
Authors
Romain Supiot Alexandre Gherardi Léopoldine du Manoir de Juaye Olfa Doghri Marine Sivignon Michaël Duruisseaux Christos Chouaid